secwatch / observer

Executive movement radar

Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.

Launch 76387 grounded facts newest September 3, 2026, 5:10 PM ET RSS · JSON

Showing 7751–7800 of 76387

Appointed

Miguel A. Lopez Ben

Director
GPRO · GoPro, Inc.
Effective
2025-04-04
Filed
April 8, 2025, 7:59 PM ET
On April 4, 2025, the Board of Directors (the “Board”) of GoPro, Inc. (the “Company”), on the recommendation of the Company’s Nominating and Governance Committee, appointed Miguel A. Lopez Ben (“Mr. Lopez”) to the Board, effective April 4, 2025.
Role change (interim)

Donald McClymont

Principal Financial Officer and Principal Accounting Officer
INDI · indie Semiconductor, Inc.
Effective
2025-05-13
Filed
April 8, 2025, 7:59 PM ET
Following Mr. Bal’s departure, the Company’s Chief Executive Officer, Donald McClymont, will assume the duties of principal financial officer and principal accounting officer while the Company conducts a search for a new Chief Financial Officer.
Departed (interim)

Kanwardev Raja Singh Bal

Chief Financial Officer, Executive Vice President and Chief Accounting Officer
INDI · indie Semiconductor, Inc.
Effective
2025-05-13
Filed
April 8, 2025, 7:59 PM ET
On April 4, 2025, Kanwardev Raja Singh Bal notified indie Semiconductor, Inc. (the “Company”) of his resignation as Chief Financial Officer, Executive Vice President and Chief Accounting Officer of the Company.
Appointed

Cynthia Hundorfean

director
AWHL · Aspira Women's Health Inc.
Effective
2025-04-06
Filed
April 8, 2025, 7:59 PM ET
On April 6, 2025, the Board appointed John Fraser and Cynthia Hundorfean as directors of the Company.
Appointed

John Fraser

director
AWHL · Aspira Women's Health Inc.
Effective
2025-04-06
Filed
April 8, 2025, 7:59 PM ET
On April 6, 2025, the Board appointed John Fraser and Cynthia Hundorfean as directors of the Company.
Appointed

Jeffrey Cohen

director
AWHL · Aspira Women's Health Inc.
Effective
2025-04-02
Filed
April 8, 2025, 7:59 PM ET
On April 2, 2025, the Board (the “Board”) of Directors of the Company appointed Jeffrey Cohen, M.D. as a director of the Company.
Appointed (interim)

Julie Carrillo

Principal Accounting Officer
AWHL · Aspira Women's Health Inc.
Effective
2025-04-04
Filed
April 8, 2025, 7:59 PM ET
On April 4, 2025, the Board appointed Julie Carrillo, the Company’s Corporate Controller, to act as the Principal Accounting Officer of the Company on an interim basis.
Departed

Steven R. Burns

Executive Vice President and Chief Administrative Officer
MAMA · Mama's Creations, Inc.
Effective
2025-04-30
Filed
April 8, 2025, 7:59 PM ET
On April 8, 2025, Steven R. Burns, Executive Vice President and Chief Administrative Officer, notified the Company of his intention to retire from the Company, including its Board of Directors, effective on or about April 30, 2025.
Appointed

Gregg Honigblum

Director
SINT · Sintx Technologies, Inc.
Effective
2025-04-03
Filed
April 8, 2025, 7:59 PM ET
The Board of Directors of SINTX Technologies, Inc. (the “Company”) appointed Jay M. Moyes, Robert D. Mitchell, Mark Anderson, Chris Lyons and Gregg Honigblum to the Board of Directors of the Company, effective April 3, 2025.
Appointed

Chris Lyons

Director
SINT · Sintx Technologies, Inc.
Effective
2025-04-03
Filed
April 8, 2025, 7:59 PM ET
The Board of Directors of SINTX Technologies, Inc. (the “Company”) appointed Jay M. Moyes, Robert D. Mitchell, Mark Anderson, Chris Lyons and Gregg Honigblum to the Board of Directors of the Company, effective April 3, 2025.
Appointed

Robert D. Mitchell

Director
SINT · Sintx Technologies, Inc.
Effective
2025-04-03
Filed
April 8, 2025, 7:59 PM ET
The Board of Directors of SINTX Technologies, Inc. (the “Company”) appointed Jay M. Moyes, Robert D. Mitchell, Mark Anderson, Chris Lyons and Gregg Honigblum to the Board of Directors of the Company, effective April 3, 2025.
Appointed

Jay M. Moyes

Director
SINT · Sintx Technologies, Inc.
Effective
2025-04-03
Filed
April 8, 2025, 7:59 PM ET
The Board of Directors of SINTX Technologies, Inc. (the “Company”) appointed Jay M. Moyes, Robert D. Mitchell, Mark Anderson, Chris Lyons and Gregg Honigblum to the Board of Directors of the Company, effective April 3, 2025.
Appointed

Mark Anderson

Director
SINT · Sintx Technologies, Inc.
Effective
2025-04-03
Filed
April 8, 2025, 7:59 PM ET
The Board of Directors of SINTX Technologies, Inc. (the “Company”) appointed Jay M. Moyes, Robert D. Mitchell, Mark Anderson, Chris Lyons and Gregg Honigblum to the Board of Directors of the Company, effective April 3, 2025.
Appointed

Lili Dai

Chief Financial Officer
HFUS · Hartford Creative Group, Inc.
Effective
2025-04-03
Filed
April 8, 2025, 7:59 PM ET
On April 3, 2025, the Board of Directors (the “ Board ”) of the Company determined by unanimous written consent to appoint Ms. Dai as the Company’s permanent Chief Financial Officer (“ CFO ”), effective April 3, 2025.
Departed

Fred W. Wagenhals

Executive Chairman and Chairman of the Board
POWW · Outdoor Holding Co
Effective
2025-04-04
Filed
April 8, 2025, 7:59 PM ET
Fred W. Wagenhals delivered notice to the Board of Directors of the Company (the “ Board ”) of his resignation from his position as the Executive Chairman of the Company and as Chairman of the Board, effective immediately.
Appointed

Niclas Adler

Board member
EDGM · Edgemode, Inc.
Filed
April 8, 2025, 7:59 PM ET
Dr. Adler was appointed as Chief Technology Officer and as a Board member of the Company
Appointed

Niclas Adler

Chief Technology Officer
EDGM · Edgemode, Inc.
Filed
April 8, 2025, 7:59 PM ET
Dr. Adler was appointed as Chief Technology Officer and as a Board member of the Company
Appointed

Jennifer Sy

Chief Accounting Officer and principal financial officer
AEON · AEON Biopharma, Inc.
Effective
2025-04-04
Filed
April 8, 2025, 7:59 PM ET
On April 3, 2025, the Board appointed Jennifer Sy, age 40, as the Company’s Chief Accounting Officer and principal financial officer, effective as of April 4, 2025.
Appointed (interim)

Jost Fischer

Interim President, Chief Executive Officer and principal executive officer
AEON · AEON Biopharma, Inc.
Effective
2025-04-04
Filed
April 8, 2025, 7:59 PM ET
On April 3, 2025, the Board formally appointed Mr. Fischer to serve as Interim President, Chief Executive Officer and principal executive officer of the Company, effective as of April 4, 2025.
Appointed

Carrie R. Locklin

Chief Accounting Officer
UNB · UNION BANKSHARES INC
Effective
2025-04-01
Filed
April 7, 2025, 7:59 PM ET
the Board of Directors of Union Bank, appointed Carrie R. Locklin, age 51, to the newly created position of Chief Accounting Officer of Union Bank.
Appointed

Karyn J. Hale

Chief Operating Officer
UNB · UNION BANKSHARES INC
Effective
2025-04-01
Filed
April 7, 2025, 7:59 PM ET
the Board of Directors of Union Bank, a wholly owned subsidiary of Union Bankshares, Inc. (the "Company") appointed Company Vice President, Treasurer and Chief Financial Officer, Karyn J. Hale, age 55, to the newly created position of Chief Operating Officer of Union Bank.
Appointed

Mark Wiedman

President
PNC · PNC FINANCIAL SERVICES GROUP, INC.
Effective
2025-04-07
Filed
April 7, 2025, 7:59 PM ET
the Board of Directors of the Corporation (the “Board”) appointed Mark Wiedman as President of the Corporation
Departed

Ted E. Parker

Director
FIRST BANCSHARES INC /MS/
Effective
2025-04-01
Filed
April 7, 2025, 7:59 PM ET
each of whom was a member of the board of directors of The First immediately prior to the Effective Time
Departed

Jonathan A. Levy

Director
FIRST BANCSHARES INC /MS/
Effective
2025-04-01
Filed
April 7, 2025, 7:59 PM ET
each of whom was a member of the board of directors of The First immediately prior to the Effective Time
Departed

M. Ray (Hoppy) Cole, Jr.

Director
FIRST BANCSHARES INC /MS/
Effective
2025-04-01
Filed
April 7, 2025, 7:59 PM ET
each of whom was a member of the board of directors of The First immediately prior to the Effective Time
Departed

Renee Moore

Director
FIRST BANCSHARES INC /MS/
Effective
2025-04-01
Filed
April 7, 2025, 7:59 PM ET
each of whom was a member of the board of directors of The First immediately prior to the Effective Time
Departed

Edward M. Christie, III

President, Chief Executive Officer and director
FLYYQ · Spirit Aviation Holdings, Inc.
Effective
2025-04-06
Filed
April 7, 2025, 7:59 PM ET
On April 6, 2025, Edward M. Christie, III, President, Chief Executive Officer and director of Spirit Aviation Holdings, Inc. (the “Company”), stepped down from his role with the Company and the Board of Directors (the “Board”).
Appointed

Michael Torok

director
AMRN · AMARIN CORP PLCUK
Effective
2025-04-04
Filed
April 7, 2025, 7:59 PM ET
On April 4, 2025, the Board of Directors (the “ Board ”) of Amarin Corporation plc (the “ Company ”) appointed Michael Torok, 46, to the Board to a term commencing on such date.
Appointed

Scott Kent

Chief Financial Officer
MCFT · MasterCraft Boat Holdings, Inc.
Effective
2025-07-01
Filed
April 7, 2025, 7:59 PM ET
Scott Kent, Vice President of Finance, will succeed Mr. Oxley as CFO, effective July 1, 2025.
Departed

Timothy M. Oxley

Chief Financial Officer
MCFT · MasterCraft Boat Holdings, Inc.
Effective
2025-06-30
Successor
Scott Kent
Filed
April 7, 2025, 7:59 PM ET
Timothy M. Oxley, Chief Financial Officer (“CFO”) of MasterCraft Boat Holdings, Inc. (the “Company”) announced his resignation as CFO, effective June 30, 2025
Appointed

John T. Treace

Chairman of the Board
TMCI · TREACE MEDICAL CONCEPTS, INC.
Filed
April 7, 2025, 7:59 PM ET
appoint John T. Treace to serve as Chairman of the Board, effective upon the expiration of James T. Treace’s current term at the Company’s 2025 Annual Meeting.
Departed

James T. Treace

Director
TMCI · TREACE MEDICAL CONCEPTS, INC.
Filed
April 7, 2025, 7:59 PM ET
his intent to retire from the Board at the expiration of his current term at the 2025 annual meeting of stockholders
Appointed

Steven L. Hoerter

director
MBX · MBX Biosciences, Inc.
Effective
2025-04-07
Filed
April 7, 2025, 7:59 PM ET
Effective as of April 7, 2025, the board of directors (the “Board”) of MBX Biosciences, Inc. (the “Company”), upon the recommendation of the Nominating and Corporate Governance Committee of the Board (the “NCG Committee”), appointed Steven L. Hoerter as a director of the Company.
Departed

Alan Pickerill

Director
Leafly Holdings, Inc. /DE
Effective
2025-04-01
Filed
April 7, 2025, 7:59 PM ET
Alan Pickerill resigned from the Board of Directors of the Company.
Appointed

Mark S. Finn

director
BBSI · BARRETT BUSINESS SERVICES INC
Effective
2025-04-07
Filed
April 7, 2025, 7:59 PM ET
On April 7, 2025, the Board of Directors (the "Board") of Barrett Business Services, Inc. (the "Company") appointed Mark S. Finn, effective April 7, 2025, to serve until the Company's 2025 annual meeting of stockholders, at which time he is expected to stand for re-election.
Departed

Peter A. Scott

Chief Financial Officer
DOC · HEALTHPEAK PROPERTIES, INC.
Effective
2025-04-02
Filed
April 7, 2025, 7:59 PM ET
On April 2, 2025, Peter A. Scott informed Healthpeak Properties, Inc. (the “Company”) of his resignation from his position as Chief Financial Officer of the Company.
Departed

Rasesh Patel

Executive Vice President, NRG Consumer
NRG · NRG ENERGY, INC.
Effective
2025-05-19
Filed
April 7, 2025, 7:59 PM ET
On April 7, 2025, NRG Energy, Inc. (the “Company”) issued a press release announcing that Rasesh Patel, Executive Vice President, NRG Consumer, has notified the Company of his retirement from the Company, effective May 19, 2025.
Appointed

Darrell Cavens

Director
MTCH · Match Group, Inc.
Filed
April 7, 2025, 7:59 PM ET
On April 6, 2025, the Board of Directors (the “Board”) of Match Group, Inc. (the “Company”) adopted a resolution appointing Darrell Cavens to the Board
Appointed

Sarbani Chaudhuri

Chief Commercial & Medical Affairs Officer
RCKT · ROCKET PHARMACEUTICALS, INC.
Effective
2025-04-07
Filed
April 7, 2025, 7:59 PM ET
On April 7, 2025, Sarbani Chaudhuri was appointed by Rocket Pharmaceuticals, Inc. (the “Company”) as the Company’s Chief Commercial & Medical Affairs Officer.
Departed (interim)

Kenneth Miller

Chief Commercial Officer
KRMD · KORU Medical Systems, Inc.
Effective
2025-04-03
Filed
April 7, 2025, 7:59 PM ET
On April 3, 2025, Kenneth Miller resigned his employment and position as Chief Commercial Officer of KORU Medical Systems, Inc. (the “Company”), effective immediately, to pursue a Chief Executive Officer role at an organization that does not compete with the Company.
Departed

Michael Gibbs

Senior Vice President, General Counsel and Corporate Secretary
T2 Biosystems, Inc.
Effective
2025-03-18
Successor
Craig R. Jalbert
Filed
April 7, 2025, 7:59 PM ET
On March 18, 2025, Michael Gibbs notified the Company of his termination of that certain Consulting Agreement between himself and the Company, dated February 15, 2025 and his resignation from his position as the Company’s Senior Vice President, General Counsel and Corporate Secretary.
Departed

Laura Adams

Director
T2 Biosystems, Inc.
Effective
2025-04-03
Filed
April 7, 2025, 7:59 PM ET
On April 3, 2025, John W. Cumming, David Elsbree, Robin Toft, Seymour Liebman and Laura Adams each notified the Company of their respective resignations as members of the Company’s Board and all committees thereof, effective as of 2;25 p.m on April 3, 2025.
Departed

John Sperzel

Chief Executive Officer and President
T2 Biosystems, Inc.
Effective
2025-03-31
Successor
Craig R. Jalbert
Filed
April 7, 2025, 7:59 PM ET
On March 31, 2025, John Sperzel notified the Company of his termination of that certain Consulting Agreement between himself and the Company, dated February 15, 2025 and his resignation from his position as the Company’s Chief Executive Officer and President.
Departed

John W. Cumming

Director
T2 Biosystems, Inc.
Effective
2025-04-03
Filed
April 7, 2025, 7:59 PM ET
On April 3, 2025, John W. Cumming, David Elsbree, Robin Toft, Seymour Liebman and Laura Adams each notified the Company of their respective resignations as members of the Company’s Board and all committees thereof, effective as of 2;25 p.m on April 3, 2025.
Departed

Robin Toft

Director
T2 Biosystems, Inc.
Effective
2025-03-31
Filed
April 7, 2025, 7:59 PM ET
On March 31, 2025, John Sperzel and Robin Toft each notified T2 Biosystems, Inc. (the “Company”) of their respective resignations as members of the Company’s board of directors (the “Board”) and all committees thereof, effective immediately.
Departed

Seymour Liebman

Director
T2 Biosystems, Inc.
Effective
2025-04-03
Filed
April 7, 2025, 7:59 PM ET
On April 3, 2025, John W. Cumming, David Elsbree, Robin Toft, Seymour Liebman and Laura Adams each notified the Company of their respective resignations as members of the Company’s Board and all committees thereof, effective as of 2;25 p.m on April 3, 2025.
Departed

David Elsbree

Director
T2 Biosystems, Inc.
Effective
2025-04-03
Filed
April 7, 2025, 7:59 PM ET
On April 3, 2025, John W. Cumming, David Elsbree, Robin Toft, Seymour Liebman and Laura Adams each notified the Company of their respective resignations as members of the Company’s Board and all committees thereof, effective as of 2;25 p.m on April 3, 2025.
Departed

John Sprague

Chief Financial Officer and Corporate Treasurer
T2 Biosystems, Inc.
Effective
2025-04-03
Successor
Craig R. Jalbert
Filed
April 7, 2025, 7:59 PM ET
On April 3, 2025, John Sprague notified the Company of his resignation from his position as the Company’s Chief Financial Officer and Corporate Treasurer.
Departed

John Sperzel

Director
T2 Biosystems, Inc.
Effective
2025-03-31
Filed
April 7, 2025, 7:59 PM ET
On March 31, 2025, John Sperzel and Robin Toft each notified T2 Biosystems, Inc. (the “Company”) of their respective resignations as members of the Company’s board of directors (the “Board”) and all committees thereof, effective immediately.
Appointed

Craig R. Jalbert

Class I Director
T2 Biosystems, Inc.
Effective
2025-04-03
Filed
April 7, 2025, 7:59 PM ET
On April 3, 2025, the Board appointed Craig R. Jalbert, age 63, as a Class I director and the Company’s Chief Executive Officer, President, Corporate Treasurer, and Corporate Secretary, effective as of 11:30 a.m. on April 3, 2025.

Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.